Hypertension Trial, Recruiting NCT07019246 Sponsor: Tongji Hospital Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT07019246
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People rated as ASA Class I, II, or III — a standard medical fitness scale used by anaesthetists to assess overall health before surgery (confirm with trial site)
  • People with a body mass index (BMI) between 18 and 28 kg/m²
  • People scheduled for a planned (non-emergency) abdominal surgery using intravenous general anaesthesia
  • People whose anaesthesia is expected to last between 1 and 4 hours

Who may not be able to join:

  • People diagnosed with septic shock or multiple organ failure within the past 14 days
  • People with high potassium levels in their blood (above 5.5 mmol/L) within the past 48 hours
  • People who have had a stroke or a temporary stroke-like episode (transient ischemic attack) within the past 3 months
  • People who have had unstable chest pain (unstable angina) or a heart attack within the past 3 months, or people with an irregular heartbeat that has not been treated or has not responded well to treatment
  • People with a pre-existing diabetes diagnosis where blood sugar levels are not well controlled, or people who have been diagnosed with diabetes-related complications before surgery (such as kidney, eye, heart, or nerve damage related to diabetes)
  • People with severe liver or kidney dysfunction
  • People scheduled for liver surgery, kidney surgery, adrenal gland surgery, or day surgery (same-day discharge procedures)
  • People whose resting blood pressure is at or above 180/110 mmHg, or whose blood pressure is very low (systolic below 90 mmHg or mean blood pressure below 65 mmHg)
  • People who have taken corticosteroids or other immune-suppressing medications for more than 10 days within the past 6 months, or people with a history of adrenal suppression or immune system disease

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Shiyong Li, Department of Anesthesiology of Tongji Hospital

Phone: 02783665480

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Tongji Hospital
Registry
ClinicalTrials.gov
Start date
1 February 2025
Est. completion
30 May 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Incidence and duration of hypotension during anesthesia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov